Interpretation of surgical perioperative management strategy of 2020 ESC guidelines for the management of adult congenital heart disease
- VernacularTitle:《2020 ESC成人先天性心脏病管理指南》外科围术期管理策略解读
- Author:
Miao TIAN
1
;
Xiaodong ZENG
1
;
Yong ZHANG
1
;
Jimei CHEN
1
Author Information
1. Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Provincial Cardiovascular Institute, Guangzhou, 510100, P.R.China
- Publication Type:Journal Article
- Keywords:
Congenital heart disease;
adult;
surgery;
perioperation;
European Society of Cardiology;
guideline
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(12):1393-1402
- CountryChina
- Language:Chinese
-
Abstract:
The diagnosis and management of congenital heart disease (CHD), the most common inborn defect, has been a tremendous success of modern medicine. With the development of diagnostic techniques, surgical procedures and interventional techniques, more than 90% of CHD children can survive to adulthood. Consequently, the prevalence of patients with CHD has shifted away from infancy and childhood towards adulthood. Adult CHD cardiology is now encompassing not only young or middle-aged adults but also patients aged above 60 years. Standardized guidelines can provide good theoretical support for the comprehensive management of adult CHD. Ten years after the European Society of Cardiology guidelines for the management of grown-up CHD released in 2010, the new version was officially released in August 2020. The new version of guidelines updated the classification and stratification of diseases, comprehensive intervention methods and intervention timing, and put forward some new concepts, new intervention standards and methods. For adult CHD that has not been repaired or needs to be repaired again, the indication and mode of surgical intervention and perioperative management have a great impact on the prognosis. The new version of the guidelines provides a detailed description of the surgical and intervention indications and methods for different diseases, and clarifies the management methods for high-risk groups. This article attempts to interpret this newly updated guideline from the perspective of a surgeon, sort out several key diseases introduced by the guideline, and strives to provide a concise and actionable guideline for domestic counterparts.
